More than 30,000 applications for the Government’s Coronavirus Job Retention Scheme – which has paid 80 per cent of staff salaries since March – have been rejected by HMRC.
Daily Mail Business Articles
GYG says coronavirus has not dented demand for big boats
The company said its order book grew from £35m to £38m in the six months to June 30, including a contract for an 80- metre vessel beginning in the final three months of this year.
MARKET REPORT: Airline stocks take off with Portugal boost
Ministers said travellers returning from the country will no longer have to go into quarantine from Saturday, prompting a surge in bookings. It is a favourite with some 1.8m Britons visiting per year.
High Street shops left behind in UK’s economic recovery
Retail sales rose above pre-pandemic levels for the first time in July – but experts said this disguised a gaping divide between online sales and bricks-and-mortar shops, which face ruin.
Hundreds of jobs at sushi chain Wasabi hang in balance
The grab-and-go food company, which employs more than 1,500 staff, has launched a controversial insolvency process called a Company Voluntary Arrangement to negotiate its rents down.
Trio are charged by the Serious Fraud Office
Former solicitor Timothy Schools, 59, David Kennedy, 67, and 47-year-old Richard Emmett are facing different charges ranging from fraud to transferring criminal property.
Tesla bigger than Walmart! Shares race past $2,000 milestone
A fresh surge in the firm’s share price has taken its market capitalisation to $373billion, eclipsing the US supermarket group’s $370billion. The stock passed the $2,000 mark on Thursday.
Coronavirus UK: Public sector debt goes above £2 TRILLION for the first time
Public sector debt has now gone above £2 trillion for the first time in history as the Government was forced to borrow cash to keep UK plc afloat during the coronavirus crisis.
ITV announces investment in Britbox Australia
It will also invest around £1million in a data software firm that owns ITV commercial partner and data analysis company InfoSum.
Drugs giant inks collaboration deal with RenalytixAI
Since March AstraZeneca has inked three significant deals with some lesser lights of the drugs sector quoted on the LSE’s alternative investment market.